Gary W Pace Cardiff Oncology, Inc. (CRDF) insider trading activity

Gary W Pace is of Cardiff Oncology, Inc.. Currently has a direct ownership of 1.33 Million shares of CRDF, which is worth approximately $3.43 Million. The most recent transaction as insider was on Jul 30, 2025, when has been sold 275,000 shares (Common Stock) at a price of $2.45 per share, resulting in proceeds of $673,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.33M

26.99% 3M change

90.71% 12M change

Total Value Held $3.43 Million

GARY W PACE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 30 2025	BUY Open market or private purchase	$673,750 $2.45 p/Share	275,000 Added 17.13%	1,330,676 Common Stock
Dec 11 2024	BUY Open market or private purchase	$910,299 $2.6 p/Share	350,115 Added 25.04%	1,047,876 Common Stock
Dec 19 2023	BUY Open market or private purchase	$41,100 $1.37 p/Share	30,000 Added 4.12%	697,761 Common Stock
Sep 15 2022	BUY Open market or private purchase	$256,500 $1.71 p/Share	150,000 Added 18.87%	644,811 Common Stock
Sep 21 2021	BUY Open market or private purchase	$202,500 $6.75 p/Share	30,000 Added 5.72%	494,811 Common Stock
Mar 23 2021	BUY Open market or private purchase	$102,400 $10.24 p/Share	10,000 Added 2.11%	464,811 Common Stock
Mar 18 2021	BUY Open market or private purchase	$31,680 $10.56 p/Share	3,000 Added 0.66%	454,811 Common Stock
Mar 04 2021	BUY Open market or private purchase	$13,905 $9.27 p/Share	1,500 Added 0.33%	451,811 Common Stock

Also insider at

PCRX

Pacira BioSciences, Inc. Healthcare

Director

GWP

Gary W Pace

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRDF shares.

Notify only if

Value

Insider Trading

Get notified when an Cardiff Oncology, Inc. insider buys or sells CRDF shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cardiff Oncology, Inc.

Track Activities on CRDF

Account